Funding Rounds
Achilles Therapeutics

Achilles Therapeutics Seed (2016, $17M)

Achilles Therapeutics

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $17.00M

Investors